Tag: Paroxetine
First of All, Do No Harm: New Directions in EU Antitrust...
The recent Paroxetine and CMA v. Pfizer/Flynn cases confirm the EU approach to pay-for-delay, respectively establish a workable approach to excessive pharmaceutical pricing at...
ECJ Ruling on Paroxetine
By James Killick, Marc Israel, Jérémie Jourdan & Aqeel Kadri (White & Case LLP)1
On January 30, 2020 (just sneaking in before Brexit), the European...
Paroxetine – The EU Court of Justice Rules on Pay-For-Delay Settlements...
Maria José Schmidt-Kessen (Copenhagen Business School)1
Introduction
While we are still awaiting the judgments in the pending appeals on pay-for-delay settlements in Lundbeck2 and Servier,3 the...
European Court of Justice Paroxetine Ruling Provides Guidance on Patent Settlement...
Jan Blockx (University of Antwerp)1
Introduction
Twelve years ago, on January 15, 2008, the European Commission used its power to conduct unannounced inspections in a sector...
